Toyama, Japan

Masayasu Kimura

This inventor holds 2 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Tobishi Yakuhin Kogyo Kabushiki Kaisha. Active years: 1992-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1992-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masayasu Kimura: Innovator in Pharmaceutical Chemistry

Introduction

Masayasu Kimura is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Masayasu Kimura holds 2 patents that reflect his expertise in creating novel chemical compounds. His latest patents include:

1. 4,6-diarylpyrimidine derivatives and salts thereof.

2. Quaternary ammonium compounds having muscle relaxation activity. This compound is represented by a complex formula that includes various functional groups, indicating its potential for diverse applications in medicine.

Career Highlights

Throughout his career, Masayasu Kimura has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Taiho Pharmaceutical Company Limited and Tobishi Yakuhin Kogyo Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation.

Collaborations

Masayasu Kimura has collaborated with esteemed colleagues in his field, including Kenji Naito and Yasuo Konno. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Masayasu Kimura's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic compounds, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…